La gestione del paziente anziano con i NAO

More documents

Recommendations

Info

Assistenza Domiciliare TAO Bologna Anno 20121° Semestre 2012• Prelievi per monitoraggio TAO 45.100• TAO sui prelievi totali 67.2%
2. Pazienti <strong>con</strong> FA di nuova diagnosi (warfarin-naïve)
Page 4:
Stroke Risk in Atrial FibrillationU
Page 7: Limiti della Terapia Anticoagulante
Page 10 and 11: A T AFRisk of non prescription of O
Page 12 and 13: Odds RatioVKA Therapeutic WindowEff
Page 15 and 16: Anticoagulation Control in Real Lif
Page 17 and 18: Patients (%)Patients Stop Taking Wa
Page 19: Atrial FibrillationNOAs Phase 3 Stu
Page 22 and 23: N Engl J Med 2009;361(12):1139-51
Page 24 and 25: Cumulative hazard ratesTIME TO FIRS
Page 26 and 27: Number of eventsHemorrhagic stroke5
Page 28 and 29: N Engl J Med August 10, 2011
Page 30 and 31: Primary Efficacy OutcomeStroke and
Page 32 and 33: Atrial FibrillationPhase 3 Study Ti
Page 34 and 35: APIXABAN Phase 3 Clinical Trial vs
Page 36 and 37: AVERROES - Primary Safety OutcomeN
Page 38 and 39: N Engl J Med August 28, 2011
Page 40 and 41: Primary OutcomeStroke (ischemic or
Page 42 and 43: Comparable Primary Efficacy Endpoin
Page 44 and 45: Quali informazioni sui NAO negli an
Page 46 and 47: Nuovi Anticoagulanti Orali non AVKV
Page 48 and 49: G Ital Cardiol 2013; 14 (3): 215 -
Page 50 and 51: 1. Pazienti già in trattamento con
Page 52 and 53: Pazienti proponibili per lo switch
Page 54 and 55: BO.N.TAOAumento pazienti con FA in
Page 56 and 57: BO.N.TAO Anno 2012Pazientiper Centr
Page 60 and 61: Pazienti warfarin - naïveI NAO son
Page 63: G Ital Cardiol 2011; 12(9): 556-65
Page 68 and 69: Raccomandazioni per la Terapia Anti
Page 70: Annual rates of ICH according to ag
show all

La gestione del paziente anziano con i NAO

Create successful ePaper yourself

Delete template?

Save as template?